Impaired memory B-cell response to the Pfizer-BioNTech COVID-19 vaccine in patients with common variable immunodeficiency-Reference-Cited by-同舟云学术

Impaired memory B-cell response to the Pfizer-BioNTech COVID-19 vaccine in patients with common variable immunodeficiency

Published:2022-01 Issue:1 Volume:149 Page:76-77
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Fernandez Salinas Ane,Piano Mortari Eva,Terreri Sara,Milito Cinzia,Zaffina Salvatore,Perno Carlo Federico,Locatelli Franco,Quinti Isabella,Carsetti Rita

Funder

Ministero della Salute

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference5 articles.

1. Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity;Hagin;J Allergy Clin Immunol,2021

2. A guide to vaccinology: from basic principles to new developments;Pollard;Nat Rev Immunol,2021

3. Considerations for the control of background fluorescence in clinical flow cytometry;Hulspas;Cytometry B Clin Cytom,2009

4. ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 3 - data analysis, reporting and case studies;Illingworth;Cytometry B Clin Cytom,2018

5. Dissection of the pre-germinal center B-cell maturation pathway in common variable immunodeficiency based on standardized flow cytometric euroflow tools;del Pino-Molina;Front Immunol,2021

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adaptive Cellular Responses following SARS-CoV-2 Vaccination in Primary Antibody Deficiency Patients;Pathogens;2024-06-18

2. An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity;Vaccines;2024-06-18

3. Antibody responses to inactivated and/or mRNA SARS-CoV-2 vaccination in patients with inborn errors of immunity;Annals of Clinical and Analytical Medicine;2024

4. SARS-CoV-2 vaccination in primary antibody deficiencies: an overview on efficacy, immunogenicity, durability of immune response and safety;Current Opinion in Allergy & Clinical Immunology;2023-11-14

5. Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies;Science Advances;2023-10-13